Bennett Jean
SEC insider (Form 3/4/5 filer). CIK 0001872219. Director at REGENXBIO Inc. (RGNX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in ROCKVILLE, MD.
Companies Bennett Jean has filed insider reports for
- REGENXBIO Inc. (RGNX): Director
- Opus Genetics, Inc. (IRD): Director
Bennett Jean
CIK: 0001872219
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)7 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 29, 2026RGNX
REGENXBIO Inc.
AwardDirect9.8K shares- - Apr 20, 2026IRD
Opus Genetics, Inc.
AwardDirect24.4K shares- - Jan 1, 2026IRD
Opus Genetics, Inc.
AwardDirect21.1K shares- - May 30, 2025RGNX
REGENXBIO Inc.
AwardDirect7.8K shares- - Apr 30, 2025IRD
Opus Genetics, Inc.
AwardDirect79.5K shares- - Jan 2, 2025IRD
Opus Genetics, Inc.
AwardDirect34K shares- - Oct 22, 2024IRD
Opus Genetics, Inc.
AwardDirect100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 |  RGNX REGENXBIO Inc. | Award | 9,807 | - | $0 | Direct |
| Apr 20, 2026 |  IRD Opus Genetics, Inc. | Award | 24,367 | - | $0 | Direct |
| Jan 1, 2026 | IRD Opus Genetics, Inc. | Award | 21,127 | - | $0 | Direct |
| May 30, 2025 | RGNX REGENXBIO Inc. | Award | 7,768 | - | - | Direct |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | Award | 79,504 | - | - | Direct |
| Jan 2, 2025 | IRD Opus Genetics, Inc. | Award | 34,021 | - | $0 | Direct |
| Oct 22, 2024 | IRD Opus Genetics, Inc. | Award | 100,000 | - | $0 | Direct |
1-7 of 7 transactions